Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Depsipeptide in Relapsed or Refractory Ovarian Carcinoma
NCT00085527Phase 2Withdrawn
- Sponsor
- University of Chicago
- Start
- May 2005
- Primary completion
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of romidepsin in ovarian epithelial cancer, sponsored by University of Chicago. Planned start May 2005; status: withdrawn.
02
Drugs
romidepsin
03
Conditions
ovarian epithelial cancer
Beyond the preview
Go deeper on NCT00085527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00085527.